Constant monitoring of vital health signs is needed in a variety of clinical environments such as intensive care units, for patients with critical health conditions, health monitoring in aged care facilities and prisons, or in safety monitoring situations where drowsiness can cause accidents.
Repare plans for Phase 3 endometrial cancer study, sidelining ovarian cancer
Repare Therapeutics announced that a combination of two targeted drugs resulted in confirmed responses of 19% and 17% in endometrial cancer and ovarian cancer, respectively
December 14, 2024